The Role of the Nuclear Factor-?B Transcriptional Complex in Cortical Immune Activation in Schizophrenia.
Ontology highlight
ABSTRACT: BACKGROUND:Transcript levels for cytokines and the viral restriction factor interferon-induced transmembrane protein are markedly higher in the prefrontal cortex in schizophrenia. These gene products are regulated by the nuclear factor-?B (NF-?B) transcriptional complex. NF-?B activity, which requires the formation of NF-?B family member heterodimers, is regulated by activation receptors, kinases, and inhibitors. Whether any of these factors are altered in schizophrenia is not known. It is also unclear whether NF-?B-related disturbances reflect ongoing cortical immune activation or a long-lasting response to a prenatal immune-related insult. METHODS:Transcript levels for NF-?B pathway markers were assessed using quantitative polymerase chain reaction in the prefrontal cortex from 1) 62 matched pairs of schizophrenia and unaffected comparison subjects, 2) antipsychotic-exposed monkeys, and 3) adult mice exposed prenatally to maternal immune activation or in adulthood to the immune stimulant polyinosinic-polycytidylic acid. RESULTS:In schizophrenia subjects, but not antipsychotic-exposed monkeys, we found higher messenger RNA levels for 1) most NF-?B family members, 2) all NF-?B activation receptors, 3) several kinases, and 4) one inhibitor (I?B?) whose transcript level is itself regulated by NF-?B activity. A similar pattern of elevated NF-?B-related messenger RNA levels was seen in adult mice that received daily polyinosinic-polycytidylic acid injections, but not in adult mice subjected to maternal immune activation in utero. CONCLUSIONS:Higher NF-?B activity, evidenced by elevated transcript levels for NF-?B family members, activation receptors, and kinases, may contribute to increased markers of cortical immune activation in schizophrenia.
SUBMITTER: Volk DW
PROVIDER: S-EPMC6289758 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA